New ICD Perspectives in the Congestive Heart Failure Patient

  • H.-J. Trappe
Conference paper


Sudden cardiac death is one of the major causes of mortality in western countries, with an incidence of 500 000 sudden deaths per year in the United States and 400 000 sudden cardiac deaths per year in Europe [1, 2]. It has been shown that the risk of sudden cardiac death increases with the severity of left ventricular (LV) dysfunction [3-5]. Although treatment for congestive heart failure (CHF) has improved markedly during the last 20 years, the prognosis is still poor in patients with severe heart failure, with an annual mortality of 50% [6]. Different studies indicate that the implantable cardioverter-defibrillator (ICD) prevents sudden cardiac death in patients with life-threatening ventricular tachyarrhythmias and impaired LV [7-9]. However, the extent of the clinical benefits of long-term survival is unclear, and it is unknown whether patients with different degrees of heart failure will benefit from ICD implantation or not.


Sudden Cardiac Death Left Ventricu Dysfunction Severe Heart Failure Ventricular Tachyarrhythmia Congestive Heart Failure Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cappucci A, Boriani G (1993) Drugs, surgery, cardioverter defibrillator: a decision based on the clinical problem. Pacing Clin Electrophysiol 16:519–526CrossRefGoogle Scholar
  2. 2.
    Gillum RF (1989) Sudden coronary death in the United States. Circulation 79:756–765PubMedCrossRefGoogle Scholar
  3. 3.
    Franciosa JA, Wilen M, Ziesche S et al (1983) Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51:831–836PubMedCrossRefGoogle Scholar
  4. 4.
    Swerdlow CD, Winkle RA, Mason JW (1983) Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med 308:1436–1442PubMedCrossRefGoogle Scholar
  5. 5.
    Bigger JT Jr, Fliess JL, Kleiger R et al (1984) The relationship among ventricular arrhythmias, left ventricular dysfunction and the mortality in the 2 years after myocardial infarction. Circulation 69:250–258PubMedCrossRefGoogle Scholar
  6. 6.
    Massie BM, Conway M (1987) Survival of patients with congestive heart failure: past, present, and future prospects. Circulation 75:11–19Google Scholar
  7. 7.
    Fogoros RN, Elson JJ, Bonnet CA et al (1990) Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying heart disease. J Am Coll Cardiol 16:381–386PubMedCrossRefGoogle Scholar
  8. 8.
    Tchou PJ, Kadri N, Anderson J et al (1988) Automatic implantable cardioverter defibrillators and survival in patients with ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med 109:529–534PubMedCrossRefGoogle Scholar
  9. 9.
    Axtell K, Tchou PJ, Akhtar M (1991) Survival in patients with depressed left ventricular function treated with implantable defibrillator. Pacing Clin Electrophysiol 14:291–296PubMedCrossRefGoogle Scholar
  10. 10.
    Moss AJ (1992) Prospective antiarrhythmic studies assessing prophylactic pharmacological and device therapy in high risk coronary patients. Pacing Clin Electrophysiol 15:694–696PubMedCrossRefGoogle Scholar
  11. 11.
    The Cardiomyopathy Trial Investigators (1993). Cardiomyopathy trial. Pacing Clin Electrophysiol 16:576–581CrossRefGoogle Scholar
  12. 12.
    Trappe HJ, Pfitzner P, Fieguth HG, Wenzlaff P, Kielblock B, Klein H (1997) Nonpharmacological therapy of ventricular tachyarrhythmias: observations in 554 patients. Pacing Clin Electrophysiol 17:2172–2177CrossRefGoogle Scholar
  13. 13.
    Trappe HJ, Klein H (1994) Clinical results with implantable cardioverter-defibrillator therapy. In: Singer I (ed) Implantable cardioverter defibrillator. Futura, Mount Kisco, NY, pp 487–505Google Scholar
  14. 14.
    Trappe HJ, Klein H, Kielblock B (1994) Role of antitachycardia pacing in patients with third generation cardioverter defibrillators. Pacing Clin Electrophysiol 17:506–513PubMedCrossRefGoogle Scholar
  15. 15.
    The Cardiac Arrhythmia Suppression Trial Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in randomized trial of arrhythmia suppression and myocardial infarction. N Engl J Med 321:406–412CrossRefGoogle Scholar
  16. 16.
    Furman S (1989) AICD benefit (editorial). Pacing Clin Electrophysiol 12:399–400PubMedCrossRefGoogle Scholar
  17. 17.
    Akhtar M, Jazayeri M, Sra J et al (1993) Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation. Pacing Clin Electrophysiol 16:511–518PubMedCrossRefGoogle Scholar
  18. 18.
    Mehta D, Saksena S, Krol RB, John T, Saxena A, Raju R, Kaushik R, Karanam R (1993) Device use patterns and clinical outcome of implantable cardioverter defibrillator patients with moderate and severe impairment of left ventricular function. Pacing Clin Electrophysiol 16:179–185PubMedCrossRefGoogle Scholar
  19. 19.
    Trappe HJ, Wenzlaff P (1995) Cardioverter defibrillator therapy as a bridge to heart transplantation. Pacing Clin Electrophysiol 18:622–631PubMedCrossRefGoogle Scholar
  20. 20.
    Wilber DJ, Garan H, Finkelstein D et al (1988) Out-of-hospital cardiac arrest: use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 318:19–24PubMedCrossRefGoogle Scholar
  21. 21.
    Lawrie GM, Pacifico A, Kaushik R et al (1991) Factors predictive of results of direct ablative operations for drug-refractory ventricular tachycardia: analysis of 80 patients. J Thorac Cardiovasc Surg 73:1239–1247Google Scholar
  22. 22.
    Stevenson WG, Stevenson LW, Middlekauf HR et al (1993) Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 88:2953–2961PubMedCrossRefGoogle Scholar
  23. 23.
    Cohn J, Johnson G, Ziesche S et al (1991) A comparison of enalapril with hydralazineisosorbide dinitrate in treatment of chronic congestive heart failure: V-Heft II. N Engl J Med 325:303–310PubMedCrossRefGoogle Scholar
  24. 24.
    Schlepper M, Neuzner J, Pitschner HF (1995) Implantable cardioverter defibrillator: effect on survival. Pacing Clin Electrophysiol 18:569–578PubMedCrossRefGoogle Scholar
  25. 25.
    Nisam S, Kaye A, Mower MM, Hull M (1995) AICD automatic cardioverter defibrillator clinical update: 14 years experience in over 34,000 patients. Pacing Clin Electrophysiol 18:142–147PubMedCrossRefGoogle Scholar
  26. 26.
    Böcker D, Block M, Isbruch F, Wietholt D, Hammel D, Borggrefe M, Breithardt G (1993) Do patients with implantable defibrillators live longer? J Am Coll Cardiol 21:1638–1644PubMedCrossRefGoogle Scholar
  27. 27.
    Axtell K, Tchou PJ, Akhtar M (1991) Survival in patients with depressed left ventricular function treated with implantable defibrillator. Pacing Clin Electrophysiol 14:291296Google Scholar
  28. 28.
    Trappe HJ, Fieguth HG, Klein H, Wenzlaff P, Weber-Conrad O, Schöhl W, Kielblock B, Lichtlen PR (1993) Role of the underlying etiology in patients with an implantable cardioverter defibrillator. Med Klinik 88:362–370Google Scholar
  29. 29.
    Swerdberg K, Idanpaan-Heikkila U, Remes J et al (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429–1435CrossRefGoogle Scholar
  30. 30.
    Ball SG, Hall AS, Mackintosh AT et al (1993) Effect of ramipril and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342:821–828Google Scholar
  31. 31.
    Myerburg RJ, Luceri RM, Thurer R et al (1989) Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 14:508–514PubMedCrossRefGoogle Scholar
  32. 32.
    Kim SG, Fisher JD, Choue CW et al (1992) Influence of left ventricular function on outcome of patients treated with implantable defibrillators. Circulation 85:1304–1310PubMedCrossRefGoogle Scholar
  33. 33.
    Vester EG, Kuhls S, Altenvoerde G et al (1994) Ten-years follow-up after automatic cardioverter/defibrillator-implantation: determining factors of survival and shock incidence (abstract) Eur J Cardiol 15:187Google Scholar
  34. 34.
    Stellbrink C, Auricchio A, Diem B, Breithardt OA, Kloss M, Schöndube FA, Klein H, Messmer B, Hanrath P (1999) Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia. Am J Cardiol 83:143D–150DCrossRefGoogle Scholar
  35. 35.
    Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Mortensen P, Klein H, for the PATH-CHF Study Group (1999) The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol 83:130D–135DGoogle Scholar
  36. 36.
    Blanc JJ, Etienne Y, Gilard M, Mansourati J, Munier S, Boschat J, Benditt DG, Lurie KG (1997) Evaluation of different ventricular pacing sites in patients with severe heart failure. Results of an acute hemodynamic study. Circulation 96:3273–3277PubMedCrossRefGoogle Scholar
  37. 37.
    Cazeau S, Ritter P, Lazarus A, Gras D, Backdach H, Mundler O, Mugica J (1996) Multisite pacing for end-stage heart failure: early experience. Pacing Clin Electrophysiol 19:1748–1757PubMedCrossRefGoogle Scholar
  38. 38.
    Myerburg RJ (2001) Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 12:369–381PubMedCrossRefGoogle Scholar
  39. 39.
    Moss AJ, Hall WJ, Cannom DS et al (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940PubMedCrossRefGoogle Scholar
  40. 40.
    Trappe HJ (2001) ICD-Therapie. In: Hombach V (ed) Interventionelle Kardiologie, Angiologie and Koronarvaskularchirurgie. Schattauer, Stuttgart, pp 550–563Google Scholar
  41. 41.
    Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hefley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882–1890PubMedCrossRefGoogle Scholar
  42. 42.
    Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883PubMedCrossRefGoogle Scholar
  43. 43.
    Cohn JN, Bristow MR, Chien KR et al (1997) Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 95:766–770PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • H.-J. Trappe
    • 1
  1. 1.Department of Cardiology and AngiologyUniversity of BochumGermany

Personalised recommendations